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Zona pellucida-induced acrosome reaction in human spermatozoa is potentiated by 
glycodelin-A via down-regulation of extracellular signal-regulated kinases and up-regulation of 
zona pellucida-induce calcium influx 
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BACKGROUND: Glycodelin-A interacts with spermatozoa before fertilization, but its role in 
modulating sperm functions is not known. Zona pellucida–induced acrosome reaction is crucial to 
fertilization and its dysfunction is a cause of male infertility. We hypothesized that glycodelin-A, a 
glycoprotein found in the female reproductive tract, potentiates human spermatozoa for zona 
pellucida-induced acrosome reaction. METHODS: Glycodelin isoforms were 
immunoaffinity-purified. The sperm intracellular cyclic-adenosine monophosphate concentration, 
protein kinase-A and extracellular signal-regulated kinase activities, and intracellular calcium were 
measured by ELISA, kinase activity assay kit and Fluo-4AM technique, respectively. The 
phosphorylation of inositol 1,4,5-trisphosphate type-1 receptor mediated by extracellular 
signal-regulated kinase was determined by Western blotting. Zona pellucida-induced acrosome 
reaction was detected by Pisum sativum staining. RESULTS: Pre-treatment of spermatozoa with 
glycodelin-A significantly up-regulated adenylyl cyclase/protein kinase-A activity and 
down-regulated the activity of extracellular signal-regulated kinase and its phosphorylation of 
inositol 1,4,5-trisphosphate type-1 receptor, and thereby enhancing zona pellucida-induced calcium 
influx and zona pellucida-induced acrosome reaction. Glycodelin-F or deglycosylated glycodelin-A 
did not have these actions. Inhibitor of protein kinase abolished while that of the extracellular 
signal-regulated kinase pathway mimic the priming activity of glycodelin-A. CONCLUSIONS: 
Glycodelin-A in the female reproductive tract sensitizes spermatozoa for zona pellucida-induced 
acrosome reaction in a glycosylation-specific manner through activation of the adenylyl 
cyclase/protein kinase-A pathway, suppression of extracellular signal-regulated kinase activation and 
up-regulation of zona pellucida-induced calcium influx. The action of glycodelin-A may be important 
in vivo to ensure full responsiveness of human spermatozoa to the zona pellucida. 
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Introduction 
Acrosome reaction is a critical event in fertilization. The zona pellucida (ZP) of the oocyte induces 
acrosome reaction. It allows the spermatozoa to release acrosomal enzymes, enabling penetration of the 
spermatozoa through the ZP. The ZP–induced acrosome reaction has been shown to be the major 
indicator of sperm fertilizing ability (Liu et al., 2007), and spermatozoa from men with defective 
ZP–induced acrosome reaction have reduced or no ability to penetrate the ZP and fertilize oocytes 
either in vivo or in vitro (Liu et al., 2004; 2007).  
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Only ~48% of the zona pellucida-bound spermatozoa from fertile men are capable of undergoing 
ZP–induced acrosome reaction in vitro (Liu et al., 2003). Human follicular fluid exerts a priming 
effect on ZP-induced acrosome reaction (Schuffner et al., 2002), i.e., follicular fluid-treated 
spermatozoa are more sensitive to the ZP-induced acrosome reaction. This is believed to enhance 
fertilization. Follicular fluid contains progesterone, which has been reported to prime the ZP-induced 
acrosome reaction in mice (Roldan et al., 1994) and guinea-pigs (Shi et al., 2005). In human, 
successive treatment with progesterone and ZP induces a higher percentage of acrosome-reacted 
spermatozoa than treatment with either progesterone or ZP alone (Schuffner et al., 2002). The temporal 
response to ZP-induced acrosome reaction is different between human spermatozoa pretreated with 
progesterone and those pretreated with follicular fluid (Schuffner et al., 2002), suggesting that other 
follicular fluid components are involved in the priming process. Apart from progesterone, no other 
components in human follicular fluid are known to have a priming effect. 
Glycodelin is an endocrine-regulated glycoprotein with four well defined glycoforms, namely 
amniotic fluid glycodelin (glycodelin-A, GdA), follicular fluid glycodelin (glycodelin-F, GdF), 
seminal plasma glycodelin (glycodelin-S, GdS) and cumulus matrix glycodelin (glycodelin-C, GdC) 
(Chiu et al., 2003a, 2007a; Seppala et al., 2007). These glycoforms have the same protein backbone 
but different glycosylation profiles. GdA and GdF inhibit spermatozoa-ZP binding (Oehninger et al., 
1995, Yeung et al., 2006) by interaction with sperm surface fucosyltransferase-5 (sFUT5), which also 
binds to the ZP (Chiu et al., 2007b). GdF, but not the other glycoforms, suppresses 
progesterone-induced acrosome reaction (Chiu et al., 2003a,b), and may thereby prevent premature 
acrosome reaction. Both GdA and GdF bind to the sperm plasma membrane overlying the acrosome. 
The binding is greatly reduced after acrosome reaction (Chiu et al., 2004) and is abolished after 
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deglycosylation of the glycoproteins (Chiu et al., 2003a,b; Yeung et al., 2006; Chiu et al., 2007b). 
The spermatozoa have to pass through the female reproductive tract before reaching the oocyte 
for fertilization. During this passage, they encounter GdA, which, in addition to the secretory 
endometrium, is also present in the oviductal fluid, follicular fluid and cumulus matrix (Seppala et al., 
2002; Yeung et al., 2006). As glycodelin modulates a variety of sperm functions (Yeung et al., 2006; 
Seppala et al., 2007), we hypothesized that GdA primes spermatozoa for ZP-induced acrosome 
reaction. In this study, we demonstrate that GdA potentiates the ZP-induced acrosome reaction in 
human spermatozoa through down-regulation of extracellular signal-regulated kinase (ERK) activity 
and up-regulation of zona pellucida-induced calcium influx.  
 
Materials and methods 
Semen samples 
The Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong 
West Cluster approved the research protocol. Spermatozoa with normal semen parameters (WHO, 
1999) from men attending the infertility clinic at Queen Mary Hospital were processed by Percoll 
(Pharmacia, Uppsala, Sweden) density gradient centrifugation (Chiu et al., 2003a). The processed 
spermatozoa were capacitated overnight as reported (Baldi et al., 1991; Whitmarsh et al., 1996; 
Ficarro et al., 2003; Shetty et al., 2003; Chiu et al., 2008a) in Earle’s balanced salt solution 
containing 0.265 mg/ml calcium chloride, 2.2 mg/ml sodium bicarbonate, 1.09 mg/ml L-lactate, 
0.033 mg/ml sodium pyruvate, 0.06 mg/ml penicillin G, 0.075 mg/ml streptomycin sulphate (EBSS; 
Flow Laboratories, Irvine, UK), and 3% bovine serum albumin (BSA) at 37°C in an atmosphere of 
5% CO2 in air. The mean percentage of capacitated spermatozoa was 43.2±2.9% (mean ± standard 
error of mean, s.e.m.) as determined by chlortetracycline staining (Chiu et al., 2005). The capacitated 
spermatozoa were resuspended in EBSS supplemented with 0.3% BSA (EBSS/BSA). 
 
Purification of glycodelin-A 
GdA was purified as described from first trimester amniotic fluid using monoclonal 
anti-glycodelin (clone F43-7F9) affinity chromatography (Chiu et al., 2003a). In brief, amniotic fluid 
diluted with Tris-buffered saline (TBS, pH 7.4) containing 0.1% Triton X-100 was loaded onto the 
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column. After successive washing of the column with TBS, 1M NaCl with 1% isopropanol, 10 mM 
ammonium acetate with 0.1% isoproponal, pH 5 and TBS, GdA was eluted by 20 mM CaCl2 
containing 0.1% trifluoroacetic acid. Deglycosylated GdA was prepared by denaturation of GdA in 
0.1% β-mecaptoethanol before incubation with 0.5 mU Peptide-N-Glycosidase F (PNGase F, 
Sigma-Aldrich Inc., St. Louis, MO) at 37°C for 24 hours. The digest was boiled for 5 minutes to 
inactivate PNGase F and dialyzed in 2 mM Tris-HCl, pH 7.5. The concentration of purified GdA was 
determined by a commercial protein assay kit (Bio-Rad, Hercules, USA).  
 
Preparation of solubilized zona pellucida 
ZPs were obtained from unfertilized human oocytes from the assisted reproduction programme 
at Queen Mary Hospital, Hong Kong. The purification of solubilized ZP was reported recently (Chiu 
et al., 2008b). Briefly, the purification involved separation of the ZP from the oocytes under 
microscope and heat-solubilization of ZP at 70°C in 5 mM NaH2PO4 buffer (pH 2.5) for 90 minutes. 
 
Determination of acrosome reaction 
Staining with fluorescein isothiocyanate labeled peanut (Pisum sativum) agglutinin (FITC-PSA; 
Sigma) and Hoechst 33258 (bisBenzimide; Sigma) were used to evaluate the acrosomal status of 
spermatozoa (Chiu et al., 2005). Processed spermatozoa were incubated with phosphate-buffered 
saline (PBS, pH 7.4) containing 0.001% (w/v) Hoechst for 10 minutes, centrifuged through 2% (w/v) 
polyvinylpyrrolidone-40 (Sigma) in PBS, fixed in 300 l of 95% ethanol and dried on slide before 
staining with 0.01% (w/v) FITC-PSA in PBS for 10 minutes. The fluorescence patterns of 150 
spermatozoa in randomly selected fields were determined under a fluorescence microscope (Zeiss, 
Oberkochen, Germany) with 600x magnification. The filter set used for Hoechst staining consisted of 
an excitation filter G365, a chromatic beam splitter FT395 and a barrier filter LP420, whereas that for 
FITC-PSA consisted of an excitation filter BP 450-490, a chromatic beam splitter FT510 and a 
barrier filter LP520. Acrosome-reacted spermatozoa were defined as those without Hoechst and 
FITC-PSA staining or with FITC-PSA staining at the equatorial segment only.  
 
Determination of cyclic-adenosine monophosphate (cAMP) 
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Intracellular cAMP was extracted in ice-cold 90% ethanol at -20°C for 30 minutes and at 4°C 
for 30 minutes as described (Chiu et al., 2005). The ethanol extracts were dried in a rotary evaporator. 
Intracellular cAMP in the extracts was determined using a non-radioactive cAMP ELISA Kit (R&D, 
Minneapolis, MN) according to the manufacturer’s instructions. 
 
Determination of protein kinase A (PKA) activities 
Spermatozoa (20 x 106) were washed thrice with PBS, sonicated in 100 μl of homogenizing 
buffer (20 mM PBS, pH 7.4 containing 2 mM EDTA, 1 mM dithiothreitol, 0.1 mM 
phenylmethanesulfonyl fluoride, 0.1 mM vanadate, 1 mM MgCl2, 100 mM NaCl and 0.05% 
Triton-X100) for 15 minutes at 4°C as described (Bajpai and Doncel, 2003). The supernatant was 
obtained after centrifugation at 15,800 g for 30 minutes at 4°C. The PKA activity in the supernatant 
was determined as described (Chiu et al., 2010) with an ELISA-based PKA (Calbiochem, San Diego, 
CA) assay kit. Standard curve was run with the test samples in each experiment. One Unit (U) of 
PKA activity was defined as the amount of enzyme required to catalyze the transfer of 1 pmol of 
phosphate to the substrates, RFARKGSLRQKNV in 1 minute at 30°C.  
 
Determination of extracellular signal-regulated kinase activity 
Sperm proteins (10×106 spermatozoa) were extracted, resolved by 12% SDS-PAGE and blotted 
on a PVDF membrane as described above. Western blotting was performed using a mouse 
monoclonal anti-phospho ERK1/2 antibody (purified IgG; 1:1000; Cell Signaling, Danvers, MA). 
Anti-tubulin antibody was used to reveal sample loading. Quantification of protein bands normalized 
with respect to the tubulin control was carried out with Image J 1.36b software 
(http://rsbweb.nih.gov/ij/index.html) and expressed as percent of the corresponding control without 
treatment. Non-radioactive ERK1/2 activity assay kit (Chemicon, Temecula, CA) was used according 
to the manufacturer’s instructions to confirm the results of the Western blotting. Results were 
expressed as percentage change over the corresponding control without treatment. 
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Determination of the effects of glycodelin-A on human zona pellucida-induced acrosome reaction 
Capacitated spermatozoa at a concentration of 2×106 spermatozoa/ml (N=5) were incubated 
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with either EBSS/BSA (control), different concentrations of GdA or GdF (0.3-300 nM) or 
deglycosylated glycodelin (0.3-300 nM) for 90 minutes at 37°C in an atmosphere of 5% CO2 in air. 
After incubation, the spermatozoa were washed twice with EBSS/BSA before further incubation with 
solubilized ZP (1 g/ml or ~0.03 ZP/µl) or EBSS/BSA (control) for 60 minutes at 37°C in an 
atmosphere of 5% CO2 in air. The acrosomal status of the treated spermatozoa was then evaluated as 
described above.  
 
Determination of the effects of glycodelin-A on adenylyl cyclase, PKA and ERK activities 
Capacitated spermatozoa (2×106/ml, N=5) were incubated with 30 nM of GdA, deglycosylated 
glycodelin or EBSS/BSA (control) at 37°C under 5% CO2 in air for 90 minutes. The intracellular 
cAMP level, PKA and ERK activity of the treated spermatozoa were evaluated as described above.  
 
Determination of the effects of PKA inhibitor on the priming effect of glycodelin-A 
To demonstrate the possible relationship between PKA activation with ERK phosphorylation 
and priming of ZP-induced acrosome reaction, the ERK activities and acrosome reaction of 
capacitated human spermatozoa (2×106, N=5) treated with 30 nM of GdA for 90 minutes in the 
presence or absence of 200 μM of Rp-Adenosine 3′,5′-cyclic monophosphorothioate 
triethylammonium salt (Rp-cAMPS, a PKA inhibitor; Calbiochem) prior to treatment with 
solubilized ZP (1 μg/ml) were determined. The spermatozoa were washed after treatment and their 
intracellular ERK activities and acrosomal status were evaluated as described above.  
 
Determination of the effects of ERK pathway inhibitors on human zona pellucida-induced 
acrosome reaction 
Capacitated spermatozoa (2×106/ml, N=5) were incubated with different concentrations of ERK 
pathway inhibitors, PD98059 (0.1-100 M), U0126/U0124 (0.01-10 M), ZM336372 (0.01-10 M), 
Raf1 kinase inhibitor I (0.01-10 M) or DMSO (control) for 90 minutes at 37°C in an atmosphere of 
5% CO2 in air. The inhibitors, PD98059 and U0126 (Calbiochem) are inhibitors of ERK1/2 
activation inhibiting mitogen-activated protein kinase kinase activities through different mechanisms, 
while U0124 (Calbiochem) is a negative control for U0126. ZM336372 and Raf1 kinase inhibitor I 
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(Calbiochem) are potent and specific inhibitor of the protein kinase c-Raf. The treated spermatozoa 
were washed twice with EBSS/BSA. They were then incubated with solubilized ZP at a 
concentration of 1 g/ml or EBSS/BSA (control) for 60 minutes at 37°C in an atmosphere of 5% CO2 
in air. After incubation, the spermatozoa were washed twice before their acrosomal status was 
evaluated as described above. 
 
Expression and localization of ERK and Raf kinase 
Proteins from capacitated spermatozoa were separated by SDS-PAGE and transferred to PVDF 
membrane for Western blot analysis as described. Affinity purified polyclonal rabbit antibodies 
against A-Raf (Cell signaling), B-Raf (ECM, Versailles, KY), c-Raf (ECM) and ERK (Cell signaling) 
were used. Horseradish peroxidase conjugated donkey anti-rabbit antibody at a dilution of 1:5000 
was used as secondary antibody. For immunostaining, capacitated spermatozoa were collected on 
glass slides by cytospin (Shandon, Pittsburgh, PA), fixed with 2% paraformaldehyde and 
permeabilized by 0.2% Triton X-100 for 20 minutes as described (Chiu et al., 2007a,b) before 
incubation with the anti-Raf (1:50) or anti-ERK (1:50) antibodies for 24 hours in a humidified 
chamber at 4°C. Bound antibodies were detected by Alexa-594-conjugated secondary antibody 
(Invitrogen, CA, USA). Antibody preabsorbed with 1:100 blocking peptide (ECM) or slides 
processed without the primary antibodies were used as controls. 
 
Determination of the effects of glycodelin-A and U0126 on human zona pellucida-induced calcium 
influx 
The relative levels of intracellular calcium within individual spermatozoon were measured 
using Fluo-4AM as described with modification (Tesarik et al., 1996; Ren et al., 2001). In brief, 
spermatozoa were loaded with 5 μM Fluo-4AM for 30 minutes at 37°C. Fifty microlitres of the 
sperm suspension (2×106/ml) with or without prior GdA (30 nM; 90 minutes) or U0126 (0.1 μM; 90 
minutes) treatment were then placed on a tissue culture dish coated with poly-L-lysine (10% 
poly-L-lysine in double distilled water) as a droplet covered with light mineral oil (Sigma). The 
spermatozoa were examined on a heated stage at 37°C under a fluorescence inverted microscope 
(Nikon, Tokyo, Japan) with ×600 magnification. Spermatozoa attached to the culture dish and with a 
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wiggling tail were selected. Fluo-4AM was excited at a wavelength of 488 nm and the emission was 
monitored at 512 nm. Fluorescence images of the selected spermatozoa were captured every second 
for a total of 60 seconds through a CCD camera under the control of an Image Pro Plus imaging 
system (Media Cybernetics, Bethesda, MD). The fluorescence signal associated with each selected 
spermatozoon in the first 5 seconds of capturing was considered as the resting fluoresecence of the 
spermatozoon. Two microlitres of solubilized ZP was then added to the sperm droplet to give a final 
concentration of 1 g/ml with the use of a micromanipulator (Nikon, Tokyo, Japan) and a 
microinjector (Narishige, Tokyo, Japan). EBSS/BSA was added to the control droplet. The 
fluorescent images of the spermatozoon were captured for a further 55 seconds. All the captured 
images were analyzed as follows: After subtraction of the background signal, each sperm head in the 
captured image was selected electronically. The intensity of the fluorescence signal within the 
selected sperm head was extracted as eight-bit grey scale measurements. The signal from the sperm 
tail or any cell that moved across the selected sperm head in the course of image capturing was 
excluded from the analysis. The raw intensity values were normalized using the equation, ∆F = [(F – 
Frest)/Frest]×100%, where ∆F was the normalized fluorescence intensity, F was the intensity at a given 
time point and Frest was the mean intensity derived from the 5 images captured before addition of ZP 
or EBSS/BSA. The experiment was performed 5 times, each involving spermatozoa from a different 
donor. Twenty spermatozoa were randomly selected from each donor for analysis. 
 
Determination of the effects of glycodelin-A on the phosphorylation of inositol 1,4,5-trisphosphate 
type-1 receptor (IP3R1) 
Capacitated spermatozoa (2×106/ml, N=3) were incubated with 30 nM of GdA or EBSS/BSA 
(control) for 90 minutes at 37°C in an atmosphere of 5% CO2 in air. The protein extract from 10×106 
spermatozoa were resolved by 5% SDS-PAGE and blotted on a PVDF membrane as described above. 
Western blotting was performed using a rabbit polyclonal anti-IP3R1 antibody (purified IgG; 0.26 
μg/ml; Abcam, Cambridge, MA). To determine the phosphorylation of IP3R1 mediated by ERK, the 
membrane was reprobed with a rabbit antibody against the phosphorylated S/TP motif 
(serine/threonine residue followed by a proline residue) of the receptor (purified IgG; 1.5 μg/ml; 
Abcam).  
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Statistical Analysis 
All the data were expressed as mean and s.e.m.. The data were analyzed by statistical softwares 
(SigmaPlot 8.02, Jandel Scientific, San Rafael, CA). For all experiments, the non-parametric repeated 
measures ANOVA on Rank test for multiple comparisons were used. If the data were normally 
distributed, Tukey Test or Parametric Student t-test was used where appropriate as the post-test. A 
probability value <0.05 was considered to be statistically significant. 
 
Results 
Glycodelin-A enhances ZP-induced acrosome reaction in a glycosylation-dependent manner 
Dose-dependent increase in acrosome reaction of spermatozoa by solubilized ZP was observed 
(Supplementary Figure S1). Statistically significant increase in acrosome reaction was detected at 
concentrations of  1 g/ml for solubilized ZP. At a concentration of 1 g/ml, solubilized ZP 
significantly increased the percentage of acrosome-reacted spermatozoa to 24.3±4.0%. This 
concentration of ZP was used in subsequent experiments in order to reduce the amount of ZP used 
and to avoid masking of the priming effect by excessive ZP stimulation at high concentrations.  
Figure 1A shows the percentages of acrosome-reacted spermatozoa above the background 
(spontaneous acrosome reaction in medium alone) in sperm samples treated with ZP or GdA alone, 
or sequentially with GdA and ZP. The extent of priming (priming index; Figure 1B) was determined 
by the difference in the percentages of acrosome-reacted spermatozoa between sequential treatment 
and sum of the two individual treatments. GdA at concentrations of ≥ 30 nM exhibited priming 
activity (Figure 1A); the percentages of acrosome-reacted spermatozoa induced by sequential 
GdAZP treatment were significantly (P<0.05) higher than the sum of the percentages of 
acrosome-reacted spermatozoa induced by GdA alone at the corresponding concentrations and by ZP 
alone. The priming index increased dose-dependently with the concentration of GdA used. At 30 nM, 
it increased 16.06.6% of the ZP-induced acrosome reaction (Figure 1B). Pre-incubation with 
differently glycosylated GdF or deglycosylated GdA did not affect the ZP-induced acrosome reaction 
at all the concentrations tested (data not shown). 
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Glycodelin-A increases intracellular cAMP concentration and PKA activity 
GdA induced a gradual increase in cAMP concentration, reaching a plateau at 60 m inutes 
(Figure 2A). The intracellular cAMP levels increased from 43.4±3.6 fmol/106 spermatozoa to 
61.6±5.1 fmol/106 spermatozoa (p<0.05) after 60 minutes of GdA treatment. Deglycosylated 
glycodelin treatment did not affect intracellular cAMP concentration of spermatozoa at any of the 
time points studied.  
Consistent with the stimulatory effect on cAMP levels, GdA also significantly increased the 
PKA activity of the treated spermatozoa when compared to those incubated in culture medium only 
(Figure 2B). The PKA activity increased from 27.5±3.4 to 40.7±4.1 U/106 spermatozoa. 
Deglycosylated glycodelin treatment had no effect on PKA activity. 
 
Glycodelin-A reduces extracellular signal-regulated kinase activity 
GdA at a concentration of 30 nM suppressed the expression of activated-ERK (Figure 2C) and 
reduced ERK activity by 63.32.3% (P<0.001, Figure 2D). Lower concentrations of GdA did not 
affect ERK activity. Again, treatment with deglycosylated glycodelin had no significant effect on 
either the activated-ERK expression or ERK activity. 
 
Protein kinase inhibitor abolishes the inhibitory effects of glycodelin-A on activated ERK1/2 level, 
ERK activity and ZP-induced acrosome reaction 
Rp-cAMPS (a PKA inhibitor) at a concentration 200 μM inhibited 35.24.5% of the sperm 
PKA activity (N=10). Compared to the control without treatment (Figure 3A upper, lane 1), 
Rp-cAMPS treatment significantly (P<0.05) increased the level of activated-ERK1/2 (Figure 3A 
upper, lane 2; Figure 3A lower, column 2) and elevated ERK activity by 59.0±21.4% in the treated 
spermatozoa (Figure 3B, column 2). Treatment with Rp-cAMPS abolished the inhibitory effect of 
GdA on activated-ERK1/2 level (Figure 3A upper, lane 3 and 4; Figure 3A lower, column 3 and 4) 
and ERK activity (Figure 3B, column 3 and 4). Rp-cAMPS also significantly (P<0.05) suppressed 
the effects of GdA on ZP-induced acrosome reaction (Figure 3C); the percentage of ZP-induced 
acrosome-reacted spermatozoa decreased from 38.74.5% (column 4) to 21.23.5% (column 5). 
Rp-cAMPS at the concentrations used did not affect ZP-induced acrosome reaction (column 2 and 3), 
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sperm viability, sperm motility and spontaneous acrosome reaction (Supplementary Table ST1). 
 
Extracellular signal-regulated kinase pathway inhibitors mimic the stimulatory effect of 
glycodelin-A on zona pellucida-induced acrosome reaction 
The percentages of spermatozoa undergoing ZP-induced acrosome reaction with and without 
pretreatment of ERK pathway inhibitors were compared. The mean percentage of spontaneously 
acrosome reacted spermatozoa before treatment was 6.9±0.7%. ERK pathway inhibitors, PD98059 
(Figure 4A), U0126 (Figure 4B), ZM336372 (Figure 4C) and Raf1 kinase inhibitor I (Figure 4C) at 
concentrations of 1 μM, 0.1 μM, ≥ 1 μM and 1 μM, respectively, significantly (P<0.05) increased the 
ZP-induced acrosome reaction. PD98059 (1 μM) and U0126 (0.1 μM) inhibited 39.23.6% and 
34.55.0% respectively of the sperm ERK activity (N=5). At high concentration (10 M), U0126 and 
Raf1 kinase inhibitor I inhibited ZP-induced acrosome reaction. U0124 (Figure 4B) had no effect on 
ZP-induced acrosome reaction except at high concentration (10 μM). The inhibitors at the 
concentrations used did not affect sperm viability, sperm motility and spontaneous acrosome reaction 
(Supplementary Table ST1). 
 
Localization of extracellular signal-regulated kinase and Raf kinase 
The antibody against non-phosphorylated ERK primarily localized ERK immunoreactivities to 
the equatorial and tail region of human capacitated spermatozoa (Supplementary Figure S2). 
Immunoreactivities were found in the acrosomal, equatorial and tail regions with the use of 
anti-phosphorylated ERK antibody (Supplementary Figures S2). The omission of the primary 
antibodies greatly reduced the signal (data not shown). 
A-raf, B-raf and c-Raf have reported molecular size of ~67, ~84 and ~73 kDa respectively. 
Anti-c-Raf antibody recognized a protein band of ~73 kDa in the human sperm extract (Figure 5B). 
Pre-absorption of the antibody with blocking peptide greatly reduced the signal. The antibodies 
against A-Raf and B-Raf did not detect the presence of A-Raf, B-Raf in the extract (Figure 5B). 
These results were consistent with the immunostaining data for Raf kinases; only positive c-Raf 
immunoreactivities were demonstrated over the head and tail of human spermatozoa (Figure 5A). 
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Glycodelin-A potentiates ZP-induced rise in the sperm intracellular calcium concentration 
Representative single spermatozoon records are shown in Figure 6. The addition of ZP induced 
a rapid rise in the sperm intracellular calcium concentration ([Ca2+]i) that peaked at 21 seconds and 
declined slowly thereafter (Figure 6A). The percentage increase of [Ca2+]i upon ZP treatment was 
significantly higher in the GdA- (334.4±43.2%, N=20; Figure 6B) or U0126-pretreated spermatozoa 
(277.4±9.2%, N=20; Figure 6C) than the control spermatozoa incubated in medium alone 
(194.3±27.3%, N=20; Figure 6A). In addition, the time taken for the [Ca2+]i to reach the peak value 
was shorter for GdA (18 seconds) or U0126-pretreated spermatozoa (16 seconds) (Figure 6B and C). 
61.94.4% and 54.63.8% of spermatozoa responded to GdA and U0126 in calcium mobilization 
respectively. Treatment with GdA (30 nM) or U0126 (0.1 μM) alone or addition of solvent vehicle 
had no effect on these parameters (data not shown).  
 
Glycodelin A suppresses phosphorylation at the S/TP motif of IP3R1 
IP3R1 is phosphorylated and subsequently downregulated by ERK in mouse cerebellum and 
B-cells (Yang et al., 2006; Bai et al., 2006; Taylor et al., 2009). Spermatozoa after GdA treatment 
had IP3R1 levels similar to the control (Figure 7). Western blotting using antibody recognizing the 
phosphorylated S/TP motif, the consensus motif phosphorylated by ERK, showed that the 
phosphorylation at the motif of IP3R1 was significantly suppressed after GdA treatment (Figure 7).  
 
Discussion 
Human oviduct cells express glycodelin mRNA and protein (Laird et al., 1995; Saridogan et al., 
1997; Yeung et al., 2006), which would interact with the spermatozoa entering the oviductal lumen. 
The concentration of glycodelin in the oviduct is higher in the secretory than in the proliferative 
phase of the menstrual cycle (Julkunen et al., 1986). GdA binds to the acrosome region of human 
spermatozoa (Chiu et al., 2003a). It does not affect spontaneous acrosome reaction and capacitation 
(Chiu et al., 2003a, 2005). The present study show that GdA, but not GdF and deglycosylated GdA, 
enhanced the ZP-induced acrosome reaction of capacitated human spermatozoa, demonstrating that the 
effect is glycosylation-dependent. We also demonstrate that the priming activity of GdA is mediated by 
down-regulation of ERK1/2 activities through the cAMP/PKA signaling pathway. This is based on 
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the findings showing that 1) GdA treatment significantly enhances the cAMP/PKA activity and 
suppresses the ERK activity; 2) PKA inhibitor diminishes the priming activity of GdA and the 
GdA-induced suppression of sperm ERK; and 3) ERK inhibitors mimic the priming effect of GdA on 
ZP-induced acrosome reaction. 
A principle target of cAMP in spermatozoa is PKA, though cAMP can also exert its effects on 
sperm functions by PKA-independent pathway such as through the exchange protein directly 
activated by cAMP (Epac) (Kinukawa et al., 2006; Branham et al., 2009). The cAMP/PKA pathway 
regulates exocytosis in a variety of secretory cells (Seino and Shibasaki, 2005). The importance of 
PKA in sperm capacitation (Visconti et al., 1995; de Lamirande et al., 1997; Aitken et al., 1998; 
O'Flaherty et al., 2004) and acrosome reaction (de Jonge, 1996; Breitbart, 2002) is also well 
established. During acrosome reaction, cAMP levels and PKA activity are increased in spermatozoa 
(Lefievre et al., 2002). PKA inhibitor (KT5720 and H89) completely prevents follicular fluid- (de 
Jonge et al., 1993) and lysophosphatidylcholine- (O'Flaherty et al., 2005) induced acrosome reaction 
of human spermatozoa. This is of interest because male mice lacking the testis-specific PKA catalytic 
subunit C are infertile and have capacitation-related defects (Nolan et al., 2004). Previous studies 
demonstrated that PKA inhibitor reduced acrosome reaction induced by high concentration of 
solubilized ZP (Bielfeld et al., 1994; De Jonge et al., 1996). We have similar observation when the 
concentration of ZP used is ≥10 g/ml. In this study, the lack of suppressive action of PKA inhibitor 
on ZP-induced acrosome reaction might be due to the reduced amount of ZP (1 g/ml) used for 
induction of acrosome reaction, which was to avoid masking of the priming effect by excessive ZP 
stimulation at high concentrations. These observations suggest different signaling pathways are 
induced by ZP depending on the dosage used. 
  The ERK pathway consists of several components including Raf (Mitogen-activated 
protein kinase kinase kinase), MEK (Mitogen-activated protein kinase kinase), and ERKs (ERK1 and 
ERK2) (Kolch, 2000). Components of the ERK cascade, such as Raf (de Lamirande and Gagnon, 
2002) and ERK (Luconi et al., 1998a,b) had been detected in human spermatozoa, and were shown to 
be positively involved in capacitation (Luconi et al., 1998a,b; de Lamirande and Gagnon, 2002; 
O'Flaherty et al., 2005, 2006; Almog and Naor, 2008). In contrast to the cAMP/PKA pathway, there 
are only few studies on the participation of the ERK pathway in acrosome reaction (du Plessis et al., 
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2001; de Lamirande and Gagnon, 2002; Liguori et al., 2005; Almog et al., 2008; Almog and Naor, 
2008). 
In this study, we provide the first evidence on the cAMP/PKA-dependent suppression of ERK 
activity mediated by GdA in human spermatozoa. cAMP/PKA may act through the Raf 
serine/threonine kinases (Cook and McCormick, 1993; Graves et al., 1993; Sevetson et al., 1993; Wu 
et al., 1993; Stork and Schmitt, 2002) to phosphorylate MEK, which in turn phosphorylates ERK at 
the tyrosine and threonine residues of the activation domain (Seger et al., 1994). There are three Raf 
family members, namely A-Raf, B-Raf and c-Raf. cAMP/PKA activates ERK in many neuronal and 
endocrine cells (Vossler et al., 1997; Dugan et al., 1999; Grewal et al., 1999) expressing B-Raf 
(Erhardt et al., 1995; Stork and Schmitt, 2002). In cells that do not express B-Raf, transfection of 
B-Raf converts cAMP from an inhibitor to an activator of ERKs (Vossler et al., 1997; Dugan et al., 
1999). In contrast, cAMP inhibits ERK activation in many nonneuronal cells expressing c-Raf, 
including NIH 3T3 cells (Schmitt and Stork, 2001), Rat-1 fibroblasts (Cook and McCormick, 1993; 
Burgering et al., 1993; Wu et al., 1993), myocytes (Graves et al., 1993), and adipocytes (Sevetson et 
al., 1993). It has been proposed that PKA phosphorylates serine-43 of c-Raf, thereby inhibiting 
Ras-dependent activation of c-Raf by preventing the binding of c-Raf to Ras (Wu et al., 1993).  
Although Raf has been detected in human spermatozoa (de Lamirande and Gagnon, 2002), the 
identity of the Raf isoform remains unknown. The present study detected c-Raf, but not A-Raf and 
B-Raf in human spermatozoa. Furthermore, Raf inhibitor promoted ZP-induced acrosome reaction, 
suggesting that the priming effect of GdA was mediated through PKA-dependent suppression of 
c-Raf, followed by down regulation of ERK activity. 
Another novel finding of the present results was that the GdA-induced decrease in ERK activity 
enhanced the ZP-induced acrosome reaction. Such a relationship was in agreement with the ability of 
ERK pathway inhibitors, PD98059, U0126, ZM336372 and Raf1 kinase inhibitor I to mimic GdA 
activity, enhancing the ZP-induced acrosome reaction. But, the enhancement was not related to a 
direct action of the inhibitors on acrosome reaction (Supplementary Table ST1). The reported actions 
of ERK pathway inhibitors on human acrosome reaction vary according to the inducer of acrosome 
reaction. PD98059 or U0126 suppress phorbol myristoyl acetate-induced (Almog et al., 2008), 
lysophosphatidylcholine- (de Lamirande and Gagnon, 2002), and A23187- (du Plessis et al., 2001), 
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but not progesterone- (Luconi et al., 1998a,b) induced acrosome reaction. PD98059 has also been 
reported to inhibit ZP-induced acrosome reaction (du Plessis et al., 2001). The reason for the 
discrepancy between these reports and the present study may be the use of different concentrations of 
PD98059. While 1 μM of PD98059 demonstrated a priming effect in our study, 50 μM of the same 
inhibitor inhibited the ZP-induced acrosome reaction in Du Plessis’ report (du Plessis et al., 2001). In 
somatic cells, PD98059 selectively inhibits ERK with IC50 of ~1-2 μM (Pang et al., 1995; Reiners et 
al., 1998; Li et al., 2008). The inhibitor at concentrations ≥ 10 μM inactivates calcium influx 
non-specifically (Gould and Stephano, 2000; Pereira et al., 2002). Non-specific activity of U0126 at 
high concentrations has also been reported (Pereira et al., 2002). Therefore, the high concentrations 
of PD98059 or U0126 may suppress the ZP-induced acrosome reaction by suppressing calcium 
influx, which is known to be important for ZP-induced acrosome reaction (Breitbart, 2002; 
Kirkman-Brown et al., 2002).  
 It is generally accepted that capacitative Ca2+ entry resulting from depletion of an intracellular 
inositol 1,4,5-trisphosphate (IP3)-gated Ca2+ store is a fundamental mediator of acrosome reaction 
(Breitbart, 2002; Kirkman-Brown et al., 2002). Therefore, the effect of GdA on Ca2+ influx was 
studied in spermatozoa. Interestingly, although GdA treatment alone did not affect sperm [Ca2+]i, it 
significantly enhanced the ZP-induced Ca2+ influx in terms of increasing the [Ca2+]i and shortening 
the time to peak [Ca2+]i upon exposure to ZP. A similar effect was observed with the use of inhibitor 
of the ERK pathway, U0126, indicating that ERK mediates the action of GdA on ZP-induced Ca2+ 
influx. 
IP3R1 regulates the IP3-gated Ca2+ store of spermatozoa (Patel et al., 1999). This is consistent 
with the expression of IP3R1 in the acrosomal region of human spermatozoa and its reduction after 
acrosome reaction (Kuroda et al., 1999). In contrast, the expression of IP3R3 remains unchanged 
after acrosome reaction and IP3R2 is absent in human spermatozoa (Kuroda et al., 1999). 
Phosphorylation is an important regulatory mechanism of IP3R1 function (Taylor et al., 2009; 
Vanderheyden et al., 2009). Activated ERK phosphorylates Ser 436 of IP3R1 and reduces its binding 
to IP3 (Yang et al., 2006; Bai et al., 2006; Taylor et al., 2009). The present results demonstrate that 
GdA suppresses ERK-mediated IP3R1 phosphorylation. Taken together, an intriguing possibility 
arises that the suppressive activity of GdA on sperm ERK reduces the phosphorylation of IP3R1, 
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ZP stimulation activates phospholipase C (Roldan and Shi, 2007), which generates IP3, thereby 
inducing release of intracellular Ca2+ through IP3-gated channels. Although GdA modulates the 
IP3R1 activity, our preliminary data show that it has no effect on the phospholipase C activity in 
spermatozoa. The differential action of GdA and ZP on phospholipase C-IP3-gated calcium channels 
may explain the lack of effect of GdA on acrosome reaction while exhibiting a priming effect on 
ZP-induced acrosome reaction. 
 GdA suppresses spermatozoa-ZP binding by blocking the binding of sFUT-5 to the ZP 
(Oehninger et al., 1995; Chiu et al., 2007b). A recent study demonstrated that sFUT5 was 
concentrated in the membrane raft at the anterior region of the sperm head in a 
capacitation-dependent manner (Nixon et al., 2009). However, sFUT5 is unlikely to be involved in 
the priming effect of GdA as sFUT5 acceptors do not have priming activity (Chiu PCN and Yeung 
WSB unpublished observation), though the acceptors can compete for the GdA binding sites on 
human spermatozoa (Chiu et al., 2007b). It is likely that another receptor of GdA yet to be identified 
is responsible for the priming activity of GdA on ZP-induced acrosome reaction. Based on the 
present results and the production of significant amount of glycodelin by the oviductal cells (Laird et 
al., 1995; Saridogan et al., 1997), we propose that GdA in the oviductal fluid binds to spermatozoa, 
potentiating them for ZP-induced acrosome reaction via the cAMP/PKA/ERK/IP3R1 pathway. 
During cumulus cell penetration, GdC in the matrix displaces sperm-bound GdA and promotes the 
zona binding capacity of the penetrated spermatozoa (Chiu et al., 2007a). It remains to be determined 
whether removal of the sperm-bound GdA would affect the sensitivity of the penetrated spermatozoa 
17 
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to ZP-induced acrosome reaction.  
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Figure 1. Effect of different concentrations of GdA pretreatment on ZP-induced acrosome reaction. 
(A) Solubilized ZP (1 μg/ml) was used to induce the acrosome reaction (N=5). *P<0.05 when 
compared with the corresponding ZP alone control. †P<0.05 when compared with the sum of 
acrosome-reacted spermatozoa after ZP alone and after GdA alone treatments. (B) Priming index of 
GdA pretreatment on ZP-induced acrosome reaction. Priming index is defined as the difference in the 
percentages of acrosome-reacted spermatozoa between sequential treatment and sum of the two 
individual treatments.  
 
Figure 2. Effects of 30 nM GdA and deglycosylated glycodelin on: (A) the intracellular cAMP level 
of human spermatozoa (N=5). *P<0.05 when compared with the corresponding control without 
glycodelin treatment; (B) PKA activity (N=5). *P<0.05 for comparison with control without 
treatment; (C) activated-ERK1/2 level (pERK1/2) (N=3). Upper: Representative images of the 
western blot result for activated-ERK1/2. Sperm protein extract (10×106/lane) were resolved by 
SDS-PAGE, transferred to PVDF membrane and probed with anti-phospho ERK1/2 antibody 
(1:1000). Anti-tubulin antibody was used to reveal sample loading. Horseradish peroxidase 
conjugated anti-rabbit antibody at a dilution of 1:5000 was used as secondary antibody. Lower: 
Semi-quantitative comparison of the pERK1/2 level. The data were mean  s.e.m. of densitometric 
measurements from three independent experiments and expressed as percent of corresponding 
control without treatment and (D) ERK1/2 activity (N=3). The results shown are obtained from three 
experiments using three samples. *P<0.05 for comparison with corresponding control without 
treatment. 
 
Figure 3. Effects of 30 nM GdA on activated-ERK1/2 level (pERK1/2), ERK1/2 activity and 
ZP-induced acrosome reaction in the presence and absence of PKA inhibitor, Rp-cAMPS. (A) Upper: 
Representative images of the western blot result for activated ERK1/2. Sperm protein extract 
(10×106/lane) were resolved by SDS-PAGE, transferred to PVDF membrane and probed with 
anti-phospho ERK1/2 antibody (1:1000). Anti-tubulin antibody was used to reveal sample loading. 
Horseradish peroxidase conjugated anti-rabbit antibody at a dilution of 1:5000 was used as secondary 
antibody. Lower: Semi-quantitative comparison of the pERK1/2 level. The data were mean  s.e.m. 
of densitometric measurements from three independent experiments and expressed as percent of 
control without treatment (N=3). (B) Comparison of the ERK1/2 activity. The results shown are 
obtained from three experiments using three samples. *P<0.05 for comparison with the no treatment 
control. †P<0.05 for comparison with the corresponding control without PKA inhibitor. (C) 
ZP-induced acrosome reaction(N=5). 1 μg/ml solubilized ZP was used to induce the acrosome 
reation. a-b, c-d, e-f, g-h P<0.05. 
 
Figure 4. Effect of different concentrations of (A) PD98059 (0.1-100 M) (B) U0126/U0124 
(0.01-10 M) and (C) raf kinase inhibitor (0.01-10 M) on ZP-induced acrosome reaction (N=3). 1 
μg/ml solubilized ZP was used to induce the acrosome reaction. *P<0.05 when compared with the 
control without inhibitor treatment. 
 
Figure 5. (A) Immuno-localization of Raf kinases in human spermatozoa. Capacitated spermatozoa 
were collected on glass slides by cytospin (Shandon), fixed with 2% paraformaldehyde and 
permeabilized by 0.2% Triton X-100 for 20 minutes before incubation with the 1:50 anti-A-Raf, 
anti-B-Raf and anti-c-Raf antibodies for 24 hours in a humidified chamber at 4°C. Bound antibodies 
were detected by Alexa-594-conjugated secondary antibody. Slides processed without the primary 
antibodies were used as controls. Scale bar: 10 μm (B) Sperm protein extract (2×106/lane) were 
resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-A-Raf, anti-B-Raf and 
anti-c-Raf antibodies (1:1000). Horseradish peroxidase conjugated anti-rabbit antibody at a dilution 
of 1:5000 was used as secondary antibody. Antibody preabsorbed with 1:100 blocking peptide was 
used as controls. PA: Anti-c-Raf pre-absorpted with 1:100 blocking peptide (control). Arrow 
indicates the 73 kDa c-Raf. 
 
Figure 6. Time courses of solubilized ZP (1 μg/ml)-induced Ca2+ changes in the head of capacitated 
human spermatozoa (A) without pretreatment, (B) with GdA pretreatment (30 nM) or (C) with 
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U0126 pretreatment (0.1 μM). The bar indicates the period of solubilized ZP exposure. 
Representative responses of 5 cells (colored traces). Mean response of all the cells (N=20 from 5 
sperm samples) in the experiment is also shown (black traces). Five greyscale images are included 
showing the signal intensity of the same spermatozoon at the time points indicated. Similar results 
were obtained in 4 other experiments. Scale bar: 4 μm 
 
Figure 7. Effects of 30 nM GdA on the phosphorylation of IP3R1 in human spermatozoa (N=3). 
Sperm protein extract (10×106/lane) were resolved by SDS-PAGE, transferred to PVDF membrane 
and probed with anti-IP3R1 antibodies (0.26 μg/ml). Phosphorylation of IP3R1 was determined by 
reprobing the membrane with antibody that recognized phosphorylated serine or threonine residue 
adjacent to a proline (pS/TP), the consensus motif phosphorylated by ERK.  
 
Figure 8. A proposed intracellular signaling network of the priming activity of glycodelin-A on 
ZP-induced acrosome reaction. The cAMP/PKA-dependent suppression of GdA on sperm ERK 
reduces the phosphorylation of IP3R1, thereby increasing its affinity to IP3 and enhancing the 
ZP-induced calcium influx and acrosome reaction. 
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